Ratings by William Blair (Steven Lichtman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/10/2026 | Cooper Companies | COO | Downgrade | Market Perform (Outperform) |
63.48 (61.21) |
-3.58% | Details | |
| 8/21/2026 | Beta Bionics, Inc. | BBNX | New Coverage | Market Perform (N/A) |
19.48 (19.16) |
-1.64% | Details | |
| 8/21/2026 | Tandem Diabetes Care | TNDM | New Coverage | Outperform (N/A) |
22.57 (17.43) |
-22.77% | Details | |
| 4/17/2026 | Enovis Corp | ENOV | New Coverage | Outperform (N/A) |
25.20 (21.08) |
-16.35% | Details | |
| 3/31/2026 | MiniMed Group | MMED | New Coverage | Outperform (N/A) |
14.35 (18.34) |
27.8% | Details | |
| 3/5/2026 | Sight Sciences Inc. | SGHT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2026 | Stryker | SYK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2026 | Zimmer Biomet | ZBH | New Coverage | Market Perform (N/A) |
99.25 (98.56) |
-0.7% | Details | |
| 2/20/2026 | Stryker | SYK | New Coverage | Outperform (N/A) |
372.66 (307.15) |
-17.58% | Details | |
| 1/30/2026 | Sight Sciences Inc. | SGHT | New Coverage | Outperform (N/A) |
6.15 (8.99) |
46.18% | Details | |
| 1/30/2026 | Cooper Companies | COO | New Coverage | Outperform (N/A) |
80.37 (63.48) |
-21.02% | Details | |
| 1/30/2026 | RxSight Inc. | RXST | New Coverage | Market Perform (N/A) |
8.91 (5.02) |
-43.66% | Details | |
| 1/30/2026 | Alcon Inc. | ALC | New Coverage | Market Perform (N/A) |
81.15 (70.17) |
-13.53% | Details |
